Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin.

AUTOR(ES)

Müllbacher, A

RESUMO

The fungal metabolite gliotoxin at low concentrations prevents mitogen stimulation of mature lymphocytes as a result of gliotoxin-induced genomic DNA degradation. Bone marrow, on the other hand, contains a subpopulation of cells resistant to gliotoxin at similar concentrations. This population includes the hemopoietic progenitor cells that grow in vitro in response to appropriate colony-stimulating factors and cells that form colonies in the spleens of lethally irradiated recipients. Gliotoxin treatment of lymph node cell-enriched bone marrow significantly delayed the onset of graft-versus-host disease in fully allogeneic bone marrow chimeras.

Documentos Relacionados

• Bone marrow–derived progenitor cells in pulmonary fibrosis
• HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
• Ratio of blood and marrow-derived cells in bone marrow transplantation.
• VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients
• Binding of Thymus- and Bone Marrow-Derived Lymphoid Cells to Antigen-Derivatized Fibers